Abstract
Genome-wide association studies (GWAS) have identified a number of loci that have strong support for their association with bipolar disorder (BD). The Psychiatric Genome-Wide Association Study (GWAS) Consortium Bipolar Disorder Working Group (PGC-BD) meta-analysis of BD GWAS data sets and replication samples identified evidence (P = 6.7 x 10(-7), odds ratio (OR) = 1.147) of association with the risk of BD at the polymorphism rs9371601 within SYNE1, a gene which encodes nesprin-1. Here we have tested this polymorphism in an independent BD case (n = 1527) and control (n = 1579) samples, and find evidence for association (P = 0.0095) with similar effect sizes to those previously observed in BD (allelic OR = 1.148). In a combined (meta) analysis of PGC-BD data (both primary and replication data) and our independent BD samples, we found genome-wide significant evidence for association (P = 2.9 x 10(-8), OR = 1.104). We have also examined the polymorphism in our recurrent unipolar depression cases (n = 1159) and control (n = 2592) sample, and found that the risk allele was associated with risk for recurrent major depression (P = 0.032, OR = 1.118). Our findings add to the evidence that association at this locus influences susceptibility to bipolar and unipolar mood disorders. Molecular Psychiatry (2013) 18, 614-617; doi:10.1038/mp.2012.48; published online 8 May 2012
Original language | English |
---|---|
Pages (from-to) | 614-617 |
Number of pages | 4 |
Journal | Molecular Psychiatry |
Volume | 18 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2013 |
Keywords
- SYNE1
- bipolar disorder
- unipolar depression
- genetics
- rs9371601
- GENOME-WIDE ASSOCIATION
- SCHIZOPHRENIA
- RELIABILITY
- RATIONALE
- CRITERIA
- LOCI